<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 27-year-old woman with a mechanical heart valve suffered multiple <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> while pregnant despite anticoagulation with high-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi>, the anti-coagulant of choice for patients with prosthetic heart valves, is teratogenic and can cause hemorrhagic complications at delivery </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> reduces thromboembolic complications, but is of uncertain efficacy </plain></SENT>
<SENT sid="3" pm="."><plain>We discuss alternatives for the prevention of thromboembolic complications in pregnant women with mechanical heart valves </plain></SENT>
</text></document>